CD4 and colorectal carcinoma: And we found that the increase of CD4+ GzmB+ T cells in CT after neoadjuvant chemotherapy led to better OS and DFS, suggesting that CD4+ GzmB+ cytotoxic T cells may play a protective role in pMMR CRC.